Abstract
patients with symptomatic pathological hyperprolactinemia were treated with bromocriptine. The evaluation, treatment, and follow-up was by a single individual, making this a large and unique homogeneous group for purposes of treatment evaluation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have